Publication | Closed Access

Use of recombinant fusion proteins and monoclonal antibodies to define linear and discontinuous antigenic sites on the dengue virus envelope glycoprotein

VaccinationDiscontinuous Antigenic SitesMolecular VirologyRecombinant Fusion ProteinsPathogenesisImmunologyVirologyProtein EngineeringAntibody EngineeringViral Structural ProteinMonoclonal AntibodiesMedicine